Chinese Premier Wen Jiabao Allocates Healthcare Investment, But Essential Drug List Delayed Again
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State Council issued additional healthcare reform plans July 8 to detail the goals of the country's ambitious reform plan. However, the release of the long-awaited essential drug list will be delayed to the end of this year, which was expected to be issued by June
You may also be interested in...
China To Issue New National Reimbursement List In November; MNC Margin Likely Lower
SHANGHAI - China plans to release a new version of the national reimbursement drug list before the end of November, and multinational companies will likely see lower prices due to a new price negotiation system
China To Issue New National Reimbursement List In November; MNC Margin Likely Lower
SHANGHAI - China plans to release a new version of the national reimbursement drug list before the end of November, and multinational companies will likely see lower prices due to a new price negotiation system
China To Issue New National Reimbursement List In November
Multinational companies will likely see lower prices due to a new price negotiation system.